OPKO Health Inc
OPK1.510USD
+0.120+8.63%
收盘 09/18, 16:00（美东）报价延迟15分钟
1.18B总市值
亏损市盈率 TTM
关于 OPKO Health Inc 公司
OPKO Health, Inc. 是一家跨国生物制药和诊断公司。该公司专注于利用其发现、开发和商业化专业知识以及新颖的专有技术。其部门包括制药和诊断。制药部门包括其在智利、墨西哥、爱尔兰、以色列和西班牙的制药业务、Rayaldee 产品销售及其制药研发。诊断部门主要包括即时诊断业务。其制药业务包括 Rayaldee，一种经美国食品药品管理局 (FDA) 批准的治疗患有三期或四期慢性肾病 (CKD) 和维生素 D 不足的成人继发性甲状旁腺功能亢进症 (SHPT) 的药物，以及 Somatrogon (hGH-CTP)，一种每周注射一次的人类生长激素注射剂。其 NGENLA (somatrogon-ghla) 是一种每周注射一次的人类生长激素类似物，适用于治疗三岁及以上的儿科患者。
公司简介
公司代码OPK
公司名称OPKO Health Inc
上市日期Nov 02, 1995
CEODr. Tony F. Cruz, Ph.D.
员工数量2997
证券类型Ordinary Share
年结日Nov 02
公司地址- -
城市- -
上市交易所NASDAQ Global Select Consolidated
国家- -
邮编- -
电话- -
网址- -
公司代码OPK
上市日期Nov 02, 1995
CEODr. Tony F. Cruz, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jane H. Hsiao, Ph.D.
Dr. Jane H. Hsiao, Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Vice Chairman of the Board, Chief Technical Officer
33.13M
--
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Executive Vice President - Administration, Director
Executive Vice President - Administration, Director
6.19M
-6.60%
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
393.51K
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
-70.95%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
-84.80%
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Independent Director
Independent Director
66.49K
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Dr. Tony F. Cruz, Ph.D.
Dr. Tony F. Cruz, Ph.D.
Chief Executive Officer, Transition Therapeutics, Inc
Chief Executive Officer, Transition Therapeutics, Inc
--
--
Dr. Roger J. Medel, M.D.
Dr. Roger J. Medel, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jane H. Hsiao, Ph.D.
Dr. Jane H. Hsiao, Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Vice Chairman of the Board, Chief Technical Officer
33.13M
--
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Executive Vice President - Administration, Director
Executive Vice President - Administration, Director
6.19M
-6.60%
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
393.51K
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
-70.95%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
-84.80%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
116.21M
77.50%
Chile
14.53M
9.69%
Spain
6.44M
4.29%
Mexico
6.23M
4.15%
Ireland
5.48M
3.65%
其他
1.06M
0.71%
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Frost Gamma Investments Trust
32.73%
Rubric Capital Management LP
6.02%
Holbrook (Bruce C)
5.09%
The Vanguard Group, Inc.
4.81%
Hsiao (Jane H)
4.17%
其他
47.18%
持股股东
持股股东
占比
Frost Gamma Investments Trust
32.73%
Rubric Capital Management LP
6.02%
Holbrook (Bruce C)
5.09%
The Vanguard Group, Inc.
4.81%
Hsiao (Jane H)
4.17%
其他
47.18%
股东类型
持股股东
占比
Corporation
41.58%
Investment Advisor
11.98%
Individual Investor
10.22%
Hedge Fund
7.37%
Investment Advisor/Hedge Fund
5.65%
Research Firm
1.03%
Bank and Trust
0.16%
Pension Fund
0.11%
Family Office
0.02%
其他
21.89%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
472
618.23M
77.88%
-578.48K
2025Q1
498
645.32M
88.41%
+25.74M
2024Q4
501
573.04M
84.80%
-7.63M
2024Q3
497
562.18M
81.01%
-12.00M
2024Q2
501
553.77M
79.70%
+8.59M
2024Q1
492
531.83M
76.52%
-21.84M
2023Q4
493
533.01M
69.65%
+31.42M
2023Q3
496
529.79M
69.24%
+23.70M
2023Q2
502
536.53M
70.13%
+25.42M
2023Q1
520
541.69M
71.63%
+67.95M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Frost Gamma Investments Trust
219.80M
27.72%
-26.90M
-10.90%
Apr 10, 2025
Rubric Capital Management LP
48.71M
6.14%
--
--
Mar 31, 2025
Holbrook (Bruce C)
40.38M
5.09%
--
--
Feb 24, 2025
The Vanguard Group, Inc.
29.42M
3.71%
+293.74K
+1.01%
Mar 31, 2025
Hsiao (Jane H)
33.13M
4.18%
--
--
Apr 02, 2025
Frost Group, L.L.C.
30.13M
3.8%
--
--
Apr 02, 2025
BlackRock Institutional Trust Company, N.A.
24.77M
3.12%
-514.39K
-2.03%
Mar 31, 2025
GJN 2021 Trust
19.91M
2.51%
--
--
Feb 24, 2025
EGN 2021 Trust
19.91M
2.51%
--
--
Feb 24, 2025
Geode Capital Management, L.L.C.
8.43M
1.06%
+43.62K
+0.52%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.44%
ProShares Hedge Replication ETF
0.02%
Proshares Ultra Russell 2000
0.02%
ProShares UltraPro Russell2000
0.02%
iShares Morningstar Small-Cap ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
SPDR Portfolio MSCI Global Stock Market ETF
0%
ALPS Medical Breakthroughs ETF
0%
Nuveen ESG Small-Cap ETF
0%
Vanguard US Momentum Factor ETF
0%
Invesco NASDAQ Future Gen 200 ETF
占比0.44%
ProShares Hedge Replication ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.02%
ProShares UltraPro Russell2000
占比0.02%
iShares Morningstar Small-Cap ETF
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
SPDR Portfolio MSCI Global Stock Market ETF
占比0%
ALPS Medical Breakthroughs ETF
占比0%
Nuveen ESG Small-Cap ETF
占比0%
Vanguard US Momentum Factor ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
